Literature DB >> 19949072

A minor catalytic activity of Src family kinases is sufficient for maximal activation of mast cells via the high-affinity IgE receptor.

Michael Poderycki1, Yoshiaki Tomimori, Tomoaki Ando, Wenbin Xiao, Mari Maeda-Yamamoto, Karsten Sauer, Yuko Kawakami, Toshiaki Kawakami.   

Abstract

Src family kinases (SFK) are critical for initiating and regulating the response of mast cells activated by engagement of the high-affinity IgE receptor, FcepsilonRI. Lyn is the predominant SFK in mast cells and has been ascribed both positive and negative roles in regulating mast cell activation. We analyzed the mast cell phenotype of WeeB, a recently described mouse mutant that expresses a Lyn protein with profoundly reduced catalytic activity. Surprisingly, we found that this residual activity is sufficient for wild-type levels of cytokine production and degranulation in bone marrow-derived mast cells after low-intensity stimulation with anti-IgE. High-intensity stimulation of lyn(-/-) bone marrow-derived mast cells with highly multivalent Ag resulted in enhanced cytokine production as previously reported, and WeeB cells displayed an intermediate phenotype. Under this latter condition, SFK inhibition using PP2 increased cytokine production in wild-type and WeeB but not lyn(-/-) cells, resulting in substantially higher levels in the PP2-treated WeeB than in lyn(-/-) cells. Restoration of wild-type and WeeB lyn alleles in lyn(-/-) cells generated activation phenotypes similar to those in nontransduced wild-type and WeeB cells, respectively, whereas a kinase-dead allele resulted in a phenotype similar to that of empty-vector-transduced cells. These data indicate that inhibition of Lyn and/or SFK activity can result in higher levels of mast cell activation than simple deletion of lyn and that only near-complete inhibition of Lyn can impair its positive regulatory functions. Furthermore, the data suggest that both positive and negative regulatory functions of Lyn are predominantly carried out by its catalytic activity and not an adaptor function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19949072      PMCID: PMC2921446          DOI: 10.4049/jimmunol.0901590

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

Review 1.  Signalling through the high-affinity IgE receptor Fc epsilonRI.

Authors:  H Turner; J P Kinet
Journal:  Nature       Date:  1999-11-25       Impact factor: 49.962

2.  Plat-E: an efficient and stable system for transient packaging of retroviruses.

Authors:  S Morita; T Kojima; T Kitamura
Journal:  Gene Ther       Date:  2000-06       Impact factor: 5.250

3.  Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation.

Authors:  Valentino Parravicini; Massimo Gadina; Martina Kovarova; Sandra Odom; Claudia Gonzalez-Espinosa; Yasuko Furumoto; Shinichiroh Saitoh; Lawrence E Samelson; John J O'Shea; Juan Rivera
Journal:  Nat Immunol       Date:  2002-07-01       Impact factor: 25.606

Review 4.  Molecular regulation of mast cell activation.

Authors:  Juan Rivera; Alasdair M Gilfillan
Journal:  J Allergy Clin Immunol       Date:  2006-06       Impact factor: 10.793

5.  Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation.

Authors:  Y Kawakami; J Kitaura; A B Satterthwaite; R M Kato; K Asai; S E Hartman; M Maeda-Yamamoto; C A Lowell; D J Rawlings; O N Witte; T Kawakami
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

6.  Enzymatic activity of the Src homology 2 domain-containing inositol phosphatase is regulated by a plasma membrane location.

Authors:  H Phee; A Jacob; K M Coggeshall
Journal:  J Biol Chem       Date:  2000-06-23       Impact factor: 5.157

7.  A kinase-dead allele of Lyn attenuates autoimmune disease normally associated with Lyn deficiency.

Authors:  Anne M Verhagen; Morgan E Wallace; Ankita Goradia; Sarah A Jones; Hayley A Croom; Donald Metcalf; Janelle E Collinge; Mhairi J Maxwell; Margaret L Hibbs; Warren S Alexander; Douglas J Hilton; Benjamin T Kile; Robyn Starr
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

8.  Cutting edge: genetic variation influences Fc epsilonRI-induced mast cell activation and allergic responses.

Authors:  Yumi Yamashita; Nicolas Charles; Yasuko Furumoto; Sandra Odom; Toshiyuki Yamashita; Alasdair M Gilfillan; Stephanie Constant; Molly A Bower; John J Ryan; Juan Rivera
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

9.  A conserved salt bridge in the G loop of multiple protein kinases is important for catalysis and for in vivo Lyn function.

Authors:  Rina Barouch-Bentov; Jianwei Che; Christian C Lee; Yating Yang; Ann Herman; Yong Jia; Anastasia Velentza; James Watson; Luise Sternberg; Sunjun Kim; Niusha Ziaee; Andrew Miller; Carie Jackson; Manabu Fujimoto; Mike Young; Serge Batalov; Yi Liu; Markus Warmuth; Tim Wiltshire; Michael P Cooke; Karsten Sauer
Journal:  Mol Cell       Date:  2009-01-16       Impact factor: 17.970

10.  Akt-dependent cytokine production in mast cells.

Authors:  J Kitaura; K Asai; M Maeda-Yamamoto; Y Kawakami; U Kikkawa; T Kawakami
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

View more
  8 in total

1.  Phospholipase C-β3 regulates FcɛRI-mediated mast cell activation by recruiting the protein phosphatase SHP-1.

Authors:  Wenbin Xiao; Jun-Ichi Kashiwakura; Hong Hong; Hiroki Yasudo; Tomoaki Ando; Mari Maeda-Yamamoto; Dianqing Wu; Yuko Kawakami; Toshiaki Kawakami
Journal:  Immunity       Date:  2011-06-16       Impact factor: 31.745

Review 2.  IgE-dependent signaling as a therapeutic target for allergies.

Authors:  Donald W MacGlashan
Journal:  Trends Pharmacol Sci       Date:  2012-06-30       Impact factor: 14.819

3.  The role of SHIP in the development and activation of mouse mucosal and connective tissue mast cells.

Authors:  Jens Ruschmann; Frann Antignano; Vivian Lam; Kim Snyder; Connie Kim; Martha Essak; Angela Zhang; Ann Hsu-An Lin; Raghuveer Singh Mali; Reuben Kapur; Gerald Krystal
Journal:  J Immunol       Date:  2012-03-19       Impact factor: 5.422

4.  Interaction of DJ-1 with Lyn is essential for IgE-mediated stimulation of human mast cells.

Authors:  Do-Kyun Kim; Michael A Beaven; Dean D Metcalfe; Ana Olivera
Journal:  J Allergy Clin Immunol       Date:  2017-10-13       Impact factor: 10.793

5.  Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation.

Authors:  Hiam Abdala-Valencia; Paul J Bryce; Robert P Schleimer; Joshua B Wechsler; Lucas F Loffredo; Joan M Cook-Mills; Chia-Lin Hsu; Sergejs Berdnikovs
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

6.  CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen.

Authors:  Shiteng Duan; Cynthia J Koziol-White; William F Jester; Scott A Smith; Corwin M Nycholat; Matthew S Macauley; Reynold A Panettieri; James C Paulson
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

7.  Nanoparticles Displaying Allergen and Siglec-8 Ligands Suppress IgE-FcεRI-Mediated Anaphylaxis and Desensitize Mast Cells to Subsequent Antigen Challenge.

Authors:  Shiteng Duan; Britni M Arlian; Corwin M Nycholat; Yadong Wei; Hiroaki Tateno; Scott A Smith; Matthew S Macauley; Zhou Zhu; Bruce S Bochner; James C Paulson
Journal:  J Immunol       Date:  2021-04-28       Impact factor: 5.422

8.  Tim-3 enhances FcεRI-proximal signaling to modulate mast cell activation.

Authors:  Binh L Phong; Lyndsay Avery; Tina L Sumpter; Jacob V Gorman; Simon C Watkins; John D Colgan; Lawrence P Kane
Journal:  J Exp Med       Date:  2015-11-23       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.